Russian Direct Investment Fund

Dr Reddy's gets DCGI nod to conduct phase 2/3 human trails of Russian COVID vaccine Sputnik V

The Hyderabad-based drug maker said in a press release that this will bea multi-center and randomised controlled study, which willinclude safety and immunogenicity study.

published on : 17th October 2020

Covid-19: Russia ties up with Dr Reddy's for vaccine trial in India, to supply 10 crore doses by December

Upon regulatory approval in India, Russia's sovereign wealth fund will supply 100 million doses of the vaccine to Dr Reddy's Laboratories.

published on : 16th September 2020

COVID-19 vaccine: Russia in touch with Indian firms

RDIF CEO Kirill Dmitriev said that several nations are interested in the production of the vaccine from countries in Latin America, Asia and the Middle East.

published on : 21st August 2020
IPL_2020